FDA Approves At-Home HPV Test, Boosting Cancer Screening Access
The FDA has cleared a new at-home HPV test kit, expanding access to cervical cancer screening and potentially reducing related mortality.
The FDA has cleared a new at-home HPV test kit, expanding access to cervical cancer screening and potentially reducing related mortality.
A medical college updated breast cancer screening guidelines, recommending biennial mammograms for average-risk women aged 50-74.
Estrogen patch demand surges after FDA warning removals, causing a 3-year supply shortage that impacts menopause treatment access.
Intermittent fasting in a 6-hour eating window over six months was linked to weight loss and lower testosterone and A1C in PCOS participants.
Colon cancer diagnosis delays led to Stage 4 metastatic disease and a rare BRAF V600E mutation, highlighting protocol gaps and genetic testing needs.